科伦博泰生物-B(06990)终止认购本金额9.8亿元的中国银行结构性存款

Core Viewpoint - Kintor Pharmaceutical announced the termination of its subscription to a structured deposit agreement with Bank of China, amounting to RMB 980 million, effective January 7, 2026, without incurring any fees or penalties due to the termination occurring within the investment cooling-off period [1] Group 1 - The company subscribed to a structured deposit agreement with Bank of China for a principal amount of RMB 980 million [1] - The termination of the subscription was made after further consideration and adjustment of the company's financial management strategy [1] - The company will not have to pay any amount or incur any additional costs or penalties due to the termination [1]